Paul Strijbos has extensive experience in the pharmaceutical and biotechnology sectors, with a career spanning over two decades. Beginning at GlaxoSmithKline from 1991 to 2005, Paul served as Development Leader and Translational Medicine Leader focusing on migraine and neuropathic pain. Following this, from 2005 to 2008, Paul held the role of Global Development Leader in Psychiatry at J&J Innovative Medicine EMEA. Subsequent positions included Global Development Leader in Cardiovascular & Metabolism at Novartis AG from 2008 to 2012, and Founding Director and Executive Vice President at Oxford PharmaGenesis AG between 2012 and 2015. Paul’s tenure at Roche from 2015 to 2018 encompassed roles such as Global Head of Rare Disease Clinical Development, Digital Health Technology Team Leader, Senior Principal Digital Innovation Leader, and Basel Site Head of Clinical Development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices